Los fundamentos de Fonar Corp son relativamente muy saludable,con una divulgación ESG media del sector.y su potencial de crecimiento es alto.Su valoración está considerada valorada de forma justa, ranking 135 de 205 en la industria de Equipamiento y suministros sanitarios.Su propiedad institucional es muy alto.A medio plazo, se espera que el precio de la acción tienda al alza.Pese a su rendimiento medio en bolsa el mes pasado, la empresa muestra unos fundamentos sólidos.Las acciones se mantienen sin una tendencia clara entre los niveles de soporte y resistencia, así que son adecuadas para el swing trading en un mercado lateral.
Puntuación de Fonar Corp
Información Relacionada
Ranking de la industria
135 / 205
Clasificación general
391 / 4521
Industria
Equipamiento y suministros sanitarios
Resistencia y Soporte
La empresa aún no ha revelado los datos relevantes.
Gráfico de radar
Precio actual
Anterior
Cobertura de medios
Últimas 24 horas
Nivel de cobertura
Muy bajo
Muy alto
Neutro
Aspectos destacados de Fonar Corp
Puntos fuertesRiesgo
FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment, and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, compliance consulting, purchasing, information technology (IT) services, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.
Sobrevalorada
El PE más reciente de la empresa es 16.37, en un rango percentil alto de 3 años.
La empresa está generando menos interés entre los inversores, con una relación de rotación de 20 días del %!.(string=-0.27)
Objetivo de los analistas
Basado en un total de
0
analistas
--
Calificación actual
--
Precio objetivo
--
Espacio en ascenso
Descargo de responsabilidad: Las calificaciones de los analistas y los precios objetivo son proporcionados por LSEG con fines informativos únicamente y no constituyen asesoramiento de inversión.
FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment, and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, compliance consulting, purchasing, information technology (IT) services, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.